scholarly journals Internalization of the interleukin 6 signal transducer gp130 does not require activation of the Jak/STAT pathway

1998 ◽  
Vol 330 (1) ◽  
pp. 47-54 ◽  
Author(s):  
Stefan THIEL ◽  
Iris BEHRMANN ◽  
Elke DITTRICH ◽  
Leon MUYS ◽  
Jan TAVERNIER ◽  
...  

Signalling receptors often undergo receptor-mediated endocytosis. In many cases this internalization is stimulated by ligand binding and activation of intrinsic receptor tyrosine kinases, resulting in a receptor down-regulation. We have analysed whether internalization of the interleukin 6 signal transducer gp130 is dependent on the activation of receptor-associated Jak kinases. By using a chimaeric receptor system we found that receptor mutants that lack box1 and therefore are not capable of activating Jak and signal transducer and activator of transcription (STAT) proteins are still endocytosed efficiently. A chimaeric receptor with the recently identified dileucine internalization motif being replaced by two alanine residues was not efficiently internalized but still capable of recruiting STATs. Furthermore an antagonistic antibody that inhibits the signalling of all interleukin-6-type cytokines via gp130 was internalized as efficiently as an agonistic one that activates the Jak/STAT pathway. Our findings suggest that the endocytosis of gp130 is signal-independent.

2009 ◽  
Vol 27 (26) ◽  
pp. 4422-4432 ◽  
Author(s):  
Mustafa Benekli ◽  
Heinz Baumann ◽  
Meir Wetzler

Signal transducer and activator of transcription (STAT) proteins comprise a seven-member family of latent cytoplasmic transcription factors that are activated through tyrosine phosphorylation by a variety of cytokines and growth factors. Aberrant activation of STATs accompanies malignant cellular transformation with resultant leukemogenesis. Constitutive activation of STATs has been demonstrated in various leukemias. A better understanding of the mechanisms of dysregulation of the STAT pathway and understanding of the cause and effect relationship in leukemogenesis may serve as a basis for designing novel therapeutic strategies directed against STATs. Mechanisms of STAT activation, the potential role of STAT signaling in leukemogenesis, and recent advances in drug discovery targeting the STAT pathway are the focus of this review.


2004 ◽  
Vol 22 (2) ◽  
pp. 361-371 ◽  
Author(s):  
David W. Sternberg ◽  
D. Gary Gilliland

Human leukemias are frequently associated with the aberrant expression of activated fusion tyrosine kinases or activated protein tyrosine kinases carrying insertional or point mutations. The activated kinase enzymes typically phosphorylate one or more signal transducer and activator of transcription (STAT) factors, which translocate to the cell nucleus and regulate the expression of genes associated with survival and proliferation. The phosphorylation and activation of STAT family members has been described in a wide range of human leukemias. Furthermore, animal models of leukemia have demonstrated the pivotal contribution of STAT activation to leukemic pathogenesis. This review discusses evidence for the functional importance of STAT activation in the biology of leukemia and current opportunities for modulating STAT proteins in the therapy of this group of diseases.


2002 ◽  
Vol 277 (42) ◽  
pp. 39666-39672 ◽  
Author(s):  
Iwona Szymkiewicz ◽  
Katarzyna Kowanetz ◽  
Philippe Soubeyran ◽  
Ana Dinarina ◽  
Stanley Lipkowitz ◽  
...  

1997 ◽  
Vol 153 (1) ◽  
pp. R1-R3 ◽  
Author(s):  
Takashi Takeda ◽  
Hirohisa Kurachi ◽  
Toshiya Yamamoto ◽  
Hiroaki Homma ◽  
Kenichirou Morishige ◽  
...  

Abstract The signal transduction mechanism involved in human placental lactogen (hPL) was studied. We have identified that hPL rapidly stimulated the tyrosine phosphorylation of at least 7 proteins including Janus Kinases (JAK1 and JAK2) and a signal transducer and activator of transcription protein (Stat3). This is the first evidence that the JAK-STAT pathway is involved in the hPL signaling. Moreover, two unknown proteins which were different from STAT proteins (Stat1, 3 and 5) in sizes were predominantly tyrosine-phosphorylated. Because human growth hormone (hGH) activates Stat1, 3, 5 and human prolactin (hPRL) activates Stat5, these results show that hPL uses a unique signal transduction pathway which is different from hGH and hPRL.


2005 ◽  
Vol 102 (6) ◽  
pp. 1915-1920 ◽  
Author(s):  
L. M. Friedman ◽  
A. Rinon ◽  
B. Schechter ◽  
L. Lyass ◽  
S. Lavi ◽  
...  

2000 ◽  
Vol 78 (5) ◽  
pp. 247-260 ◽  
Author(s):  
Christian Wiesmann ◽  
Yves A. Muller ◽  
Abraham M. de Vos

1996 ◽  
Vol 271 (10) ◽  
pp. 5487-5494 ◽  
Author(s):  
Elke Dittrich ◽  
Carol Renfrew Haft ◽  
Leon Muys ◽  
Peter C. Heinrich ◽  
Lutz Graeve

2006 ◽  
Vol 281 (31) ◽  
pp. 21640-21651 ◽  
Author(s):  
Shlomo Oved ◽  
Yaron Mosesson ◽  
Yaara Zwang ◽  
Elena Santonico ◽  
Keren Shtiegman ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document